November 29, 2012
Compiled & Edited by Sue Emerson – Publisher
Prior Edition: November 5, 2012
List of all News/Updates
MEDICATION-ASSISTED TREATMENT (MAT) AND OPIOID ABUSE/ADDICTION
- Benzodiazepine & MAT Conference Videos Available From IRETA
- Blog: Benzos at the Opioid Treatment Program
- Blog: PTSD at the Opioid Treatment Program
- The Beginning of the End of the Abstinence Rule?
- Perspective: Docs Feel Pressure to Give Addicts Opioids
- U.S. Addiction Diagnoses up 70 Percent
- New Infographic From NIDA – Maternal Opiate Use and Newborns Suffering From Opiate
Withdrawal Are On The Rise in The U.S.
On February 9, 2012 the Philadelphia Department of Behavioral Health and Intellectual Disability Services, the Institute for Research, Education, and Training in Addictions (IRETA), and Community Care Behavioral Health hosted a kickoff conference in Philadelphia that will lead to working guidelines for the management of benzodiazepines in medication-assisted treatment.
“A push to treat chronic pain and financial disincentives for treating addiction may pressure clinicians into prescribing opioids for patients who are already addicted, a researcher suggested.
“These slides are meant as a primer on some of the biggest stories to have emerged in addiction neuroimaging, and the insights they give. Of course, these examples are only a thin sliver of the available science—and scientists are still grappling with addiction’s overwhelming complexity. Without dismissing other relevant brain systems or equally important socio-cultural and environmental influences, our focus here is the striatum: a set of structures heavily involved in reward, motivation, habit formation—and the brain’s dopamine system.”